Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis

Developmental Cell
Jialiang HuangJian Xu

Abstract

Enhancers are the primary determinants of cell identity, but the regulatory components controlling enhancer turnover during lineage commitment remain largely unknown. Here we compare the enhancer landscape, transcriptional factor occupancy, and transcriptomic changes in human fetal and adult hematopoietic stem/progenitor cells and committed erythroid progenitors. We find that enhancers are modulated pervasively and direct lineage- and stage-specific transcription. GATA2-to-GATA1 switch is prevalent at dynamic enhancers and drives erythroid enhancer commissioning. Examination of lineage-specific enhancers identifies transcription factors and their combinatorial patterns in enhancer turnover. Importantly, by CRISPR/Cas9-mediated genomic editing, we uncover functional hierarchy of constituent enhancers within the SLC25A37 super-enhancer. Despite indistinguishable chromatin features, we reveal through genomic editing the functional diversity of several GATA switch enhancers in which enhancers with opposing functions cooperate to coordinate transcription. Thus, genome-wide enhancer profiling coupled with in situ enhancer editing provide critical insights into the functional complexity of enhancers during development.

Citations

Jan 15, 2017·Experimental Hematology·Miguel Vidal, Katarzina Starowicz
Feb 12, 2017·Experimental Hematology·Constanze Bonifer, Peter N Cockerill
Feb 10, 2017·Blood·Koichi R KatsumuraUNKNOWN GATA Factor Mechanisms Group
Apr 16, 2017·Experimental Hematology·Andrea A PerreaultBryan J Venters
Jun 1, 2017·Nature Communications·Ha Youn ShinLothar Hennighausen
Dec 20, 2017·Journal of Cell Communication and Signaling·Stephanie L FrostGeorge Bou-Gharios
Feb 2, 2018·Current Opinion in Hematology·Andrea A Perreault, Bryan J Venters
Dec 3, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Cia-Hin Lau, Yousin Suh
Feb 14, 2018·Nucleic Acids Research·Raquel FueyoMarian A Martínez-Balbás
Feb 28, 2018·Cellular and Molecular Life Sciences : CMLS·Leonidas Benetatos, George Vartholomatos
Oct 5, 2017·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Steven Blinka, Sridhar Rao
Dec 4, 2017·Cold Spring Harbor Symposia on Quantitative Biology·Sarah C Hsu, Gerd A Blobel
Mar 7, 2018·Nature Communications·Jialiang HuangGuo-Cheng Yuan
Jan 18, 2018·Nature·Linda T VoGeorge Q Daley
Oct 2, 2019·IUBMB Life·Oriana Romano, Annarita Miccio
Aug 28, 2019·Proceedings of the National Academy of Sciences of the United States of America·Zhaoning WangEric N Olson
Sep 12, 2020·Microscopy Research and Technique·Maria MazzariniAnna Rita Migliaccio
Apr 5, 2016·Oral Diseases·A Peterson
Jul 5, 2016·Nature Genetics·Deborah HayDouglas R Higgs
Oct 8, 2018·Epigenetics & Chromatin·Louie N van de LagemaatDouglas Vernimmen
Feb 1, 2020·Cell Death & Disease·Jiahuan ChenBing Zhang
Mar 8, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Leonidas BenetatosGeorge Vartholomatos
Sep 29, 2020·Cancer Management and Research·Jianlong ZhouWenhua Huang
Oct 29, 2017·Stem Cells Translational Medicine·Chiara AntonianiAnnarita Miccio
Dec 12, 2018·Médecine sciences : M/S·Cécile K Lopez, Thomas Mercher
Oct 24, 2018·Development·Mathieu TremblayMaxime Bouchard

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.